vTv Therapeutics (VTVT) Interest Coverage Ratio Growth (1y) (2015 - 2023)
Powered by 
Analysis
vTv Therapeutics (VTVT) Interest Coverage Ratio Growth (1y) (2015 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 17.76% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 38.91% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 63.37% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 93.04% |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | -25.59% |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 34.31% |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 36.39% |
| Sep 30, 2023 | -88.72% |
| Dec 31, 2022 | 42.90% |
| Sep 30, 2022 | -166.17% |
| Dec 31, 2021 | -6,878.72% |
| Sep 30, 2021 | -2,116.96% |
| Dec 31, 2020 | 221.00% |
| Sep 30, 2020 | 10.26% |
| Jun 30, 2020 | -103.12% |
| Mar 31, 2020 | -477.66% |
| Dec 31, 2019 | -4,678.15% |
| Sep 30, 2019 | -645.31% |
| Jun 30, 2019 | 8.43% |
| Mar 31, 2019 | 35.90% |
| Dec 31, 2018 | 96.85% |
| Sep 30, 2018 | 86.75% |
| Jun 30, 2018 | 32.85% |
| Mar 31, 2018 | 56.58% |
| Dec 31, 2017 | 55.52% |
| Jun 30, 2017 | 99.90% |